Onconano Medicine

OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.

Funding reportedLast round: Series B

Alternative MedicineDallas, United States

What company datasets say Onconano Medicine raised

Funding, as reported

Reported in all$188Min dollars

Rounds7

Last roundSeries B

Last round dateOct 2021

Investors listed4

SEC Form D$234M sold, 8 filings, last Oct 2026

From Onconano Medicine's own website: 1 founder, 1 on the team.

John DyettCo-Founder and Managing Director

Investors who name them

Each firm lists Onconano Medicine on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put Onconano Medicine in front of investors. Or tell us what we have wrong.